GMP of Health Supplement
Set up a joint venture with Taiwan Industrial Technology Research Institute (ITRI) to develop a new botanical drug that helps the human body to repair cardiac muscle cells.
Passed PIC/S GMP audit by TFDA (Taoyuan Master Plant).
First approved by Japan PMDA audit (Kuan Yin Plant)/First approved by U.S. FDA audit (Taoyuan Master Plant).
Approved by Korea FDA audit (Taoyuan Master Plant)/Passed PIC/S GMP audit by TFDA (Kuan Yin Plant).
Approved by Belarus FDA audit (Taoyuan Master Plant).
First approved by Japan PMDA audit (Taoyuan Master Plant).
API, Bisoprolol Fumarate, filed in U.S. DMF.
Taoyuan Master Plant and Kuan Yin plant got Accreditation of Foreign Drug Manufacturer (sterile and non-sterile products) from MHLW Japan. Veterans Pharmaceutical Plant acquired.
Kuan Yin Plant acquired from Fujisawa Pharmaceutical.
Beijing Sintong Biotech Co., Ltd. established in China.
Health Food plant at Hsinchu established.
Renamed as Taiwan Biotech Co., Ltd.
Established U.S. subsidiary, Optics Lab., and started exporting eye care products to the U.S. market.
Started exporting 20ml BFS Injectables to Japan.
Launched Anpo (Ritodrine) in China.
Launched innovative transdermal nicotine patch.
Invested in Huaneng Pharmaceutical Inc. in China.
Joint development of TDDS patch with an U.S. pharmaceutical development company
Passed GMP inspection in Taiwan/Exported vitamin injection to Vietnam, and began global expansion.
First BFS (Blow-Fill-Seal) machine installed.
Company reorganized as Sintong Chemical.
Company predecessor, Glucose Corporation, established.